CEACAM1 blockade, through 5F4 (CEACAM1 monoclonal antibody) or NE inhibitor Sivelestat, can significantly decrease colonic carcinoma migration, suggesting that CEACAM1 is key to cancer cell metastasis (41). This evidence concerns the gene CEACAM1 and cancer.